Laminectomy has been widely considered one of the most common treatments for lumbar disorders. Epidural fibrosis (EF) is a common complication after laminectomy, causing recurrent postoperative pain. Schisandrin B (Sch.B), the active ingredient extracted from Schisandra chinensis Fructus, has been found to have potent antiproliferative and antifibrotic effects on several cells. This study aimed to investigate the effects of Sch.B on the prevention of postlaminectomy EF formation. In vitro, we studied the effects of Sch.B on transforming growth factor beta 1 (TGF-β1)-induced proliferation and extracellular matrix (ECM) production of primary fibroblasts, as well as its underlying mechanism. We found that Sch.B not only inhibited the proliferation of fibroblasts but also reduced ECM production, including that of connective tissue growth factor, fibronectin, and type I collagen, in a dose-dependent manner.
stenosis (Burton et al., 1981) . Treating this situation with surgery is difficult and carries high risks due to possible complications, including nerve root injuries and dura tears (Brzezicki et al., 2011; Yakovlev, Timchenko, & Parmentier, 2014) . Therefore, nonsurgical therapy to reduce scar adhesion formation after laminectomy is needed. Although the pathogenesis of EF remains unclear, the altered control of fibroblast proliferation and extracellular matrix (ECM) production reportedly plays predominant roles in the development of EF following laminectomy (Xu et al., 2015; Yan et al., 2013; Zhang, Kong, Liu, et al., 2014) . Transforming growth factor beta 1 (TGF-β1) has been reported to be the key initiating factor of EF, whereas excessive TGF-β1 signalling leads to a wide range of diseased phenotypes, including cell proliferation and ECM overproduction (Penn, Grobbelaar, & Rolfe, 2012; Yan et al., 2013; Zhang et al., 2013) . Therefore, inhibition of TGF-β1 or TGF-β1-related pathways to reduce the cell proliferation and ECM overproduction of fibroblasts may be promising therapeutic approaches to attenuate the progression of EF.
TGF-β1-induced proliferation and ECM overproduction of fibroblasts are chiefly regulated by the Smad2/3 pathway (Lakos et al., 2004; Wu, Wu, Fang, & Lan, 2012) . TGF-β1 stimulation triggers phosphorylation of the receptor-activated transcription factors Smad2/3, resulting in the formation of heteromeric complexes with Smad4 and their translocation into the nucleus. In the nucleus, the heterocomplexes recruit several transcription factors and bind to specific sequences in the promoter regions of target genes to initiate the fibrotic process (Massague & Wotton, 2000; Nakao et al., 1997) . Mitogen-activated protein kinases (MAPKs), a large group of proteins, have also been shown to participate in a diverse array of cellular programs, including regulation of TGF-β1 stimulation, representing an important mechanism for Smadindependent TGF-β1 signalling (Javelaud & Mauviel, 2004; Massague & Wotton, 2000) . Recently, interactions between Smad and MAPKs have drawn increasing attention among researchers. TGF-β1-induced MAPK activation regulates the transcriptional activity or capacity of the Smad complex (Derynck & Zhang, 2003; Javelaud & Mauviel, 2004) .
Schisandrin B (Sch.B), the most abundant dibenzocyclooctadiene lignan isolated from Schisandra chinensis Fructus, exerts diverse pharmacological activities such as antioxidative, anti-inflammatory, antiproliferation, and antifibrosis effects (Chun et al., 2014; Min et al., 2008; Thandavarayan et al., 2015) . Sch.B suppresses CCL4-induced liver fibrosis by inhibiting theTGF-β/Smad signalling pathway (Q. Chen, Zhang, et al., 2017) . Sch.B also potently suppresses Smad2/3 activity by reducing its phosphorylation and translocation into the nucleus as well as the MAPK pathway in vascular smooth muscle cells (Park et al., 2012) . However, its effect on treating EF remains unknown. Thus, we investigated the antiproliferation and anti-ECM production effects of Sch.B onTGF-β1-stimulated primary fibroblasts as well as its underlying mechanisms. Furthermore, the protective role of Sch.B against EF was examined in a postlaminectomy rat model.
| MATERIALS AND METHODS

| Ethics statement
The study was approved by the Animal Care and Use Committee at the Wenzhou Medical College (NO: wydw2017-0007). All surgical interventions, treatments, and post-operative animal care procedures were performed in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals.
| Reagents and antibodies
Sch.B (purity>98%) was purchased from Nantong Feiyu Biological Technology Co., Ltd. (Nantong, China). Sch.B was dissolved in dimethyl sulfoxide (DMSO) as a 100-mM stock solution and was stored at −20°C. Further dilution was done in cell culture medium.
Primary antibodies against JNK, p-JNK, ERK, p-ERK, p38, and p-p38 were obtained from Cell Signaling Technology (Beverly, MA, USA).
Connective tissue growth factor (CTGF), type I collagen, fibronectin, p-Smad2, p-Smad3, Smad2/3, and β-actin antibodies were purchased from Abcam (Cambridge, UK), and goat anti-rabbit and anti-mouse IgG-HRP were from Bioworld (OH, USA). Recombinant human TGF-β1 was purchased from PeproTech (NJ, USA). DMSO and collagenase I were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Cell culture reagents were purchased from Gibco (Grand Island, NY, USA).
| Fibroblast culture
Primary fibroblasts were isolated from epidural scar tissue of the 4-week postlaminectomy rat model. The cultured extracted fibroblasts were cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco, Grand Island, NY), containing 10% fetal bovine serum and a 1% antibiotic mixture of penicillin and streptomycin, and they were incubated in an atmosphere of 95% air and 5% CO 2 at 37°C. Fibroblasts from Passages 2 to 5 were then used in this study. Cells were incubated for 24 hr to reach 70-80% confluence and were starved for 24 hr in serum-free DMEM and then treated with 10-ng/ml TGF-β1, alone or in combination with Sch.B at various concentrations (5, 10, 20, 50, and 100 μM) for 72 hr.
| Cell viability
The cytotoxicity of Sch.B was assayed with the cell counting kit-8 (CCK-8; Dojindo, Tokyo, Japan) according to the manufacturer's protocol. Briefly, second-passage fibroblast cells were plated in 96-well plates (5 × 10 3 cells per well) for 24 hr and were then treated with various concentrations (5, 10, 20, 50, and 100 μM) of Sch.B for another 24 and 72 hr. At the indicated times, the cells were washed with phosphate buffered saline (PBS), and then 100 ml of DMEM containing 10 ml of CCK-8 solution was added to each well, followed by incubation at 37°C for 2 hr. Then, the optical density was measured at a wavelength of 450 nm with a spectrophotometer (Thermo Fisher).
| Cell proliferation
Second-passage fibroblasts were seeded at a density of 3 × 10 3 cells per well with complete medium in 96-well plates for 24 hr. After starvation for 24 hr, cells were treated with 10-ng/ml TGF-β1 in 0.5% fetal bovine serum supplemented DMEM, alone or in combination with Sch.B at various concentrations (5, 10, and 20 μM) for 72 hr.
Then, CCK-8 solution was added to each well as described above, and the optical density was measured. . All mRNA quantification data were normalized to GADPH as an endogenous control for mRNA detection. The data were processed using the 2 −ΔΔCt method. Details of the primers are shown in Table 1 .
| EdU incorporation assay
| Western blotting analysis
Western blotting was performed using routine protocols. The protein was extracted from epidural scar tissues and treated fibroblasts using radioimmune precipitation assay (RIPA) buffer. Then, the protein concentrations were measured using a BCA protein assay kit (Beyotime). Equal amounts of total proteins were subjected to electrophoresis on sodium dodecyl sulphate polyacrylamide gels and were transferred onto nitrocellulose membrane (LifeTechnologies, Gaithersburg, MD, USA). After being blocked with 5% nonfat milk for 2 hr, the membranes were incubated overnight at 4°C with primary antibodies against CTGF, type I collagen, fibronectin, cyclin D1, p-Smad2, p-Smad3, Smad2/3, p-Erk/Erk, p-JNK/ JNK, p-p38/p38, and β-actin. The membranes were then washed three times in TBST and incubated with their respective secondary antibodies for 2 hr at room temperature. The immune complexes were visualized by electrochemiluminescence plus reagent (Invitrogen). The intensity was quantified using the ChemiDoc™ XRS Imaging System (Bio-Rad).
| Animal models
Forty-two 3-month-old male Sprague-Dawley rats were purchased from the Animal Center of the Chinese Academy of Sciences, Shanghai, China, and were randomly divided into sham group (n = 6), control group (n = 18), and Sch.B group (n = 18). Animals were anaesthetized by intraperitoneal injection with 2% (w/v) pentobarbital (40 mg/kg) and were fixed on the operation board in the prone position. The rat laminectomy surgical procedure was performed as previously described (Sun et al., 2007) . The animals were shaved in the area near the first lumbar vertebra, and the surgical field was disinfected with povidone-iodine and draped with sterile towels. A dorsal midline incision was made between the 12th thoracic and third lumbar vertebrae, and the dura mater of L2 level was exposed after removing the spinous process and vertebral plate with a rougeur. All procedures were completed without injuring the neural tissues. Rats in the sham group were subjected to the same surgical procedure with the spinous process and vertebral plate, were exposed for 2 min, but did not undergo the laminectomy. Sch.B was dissolved in DMSO at 15 mg/ml and was then diluted with normal saline. After surgery, Sch.B solution was injected intraperitoneally at 20 mg·kg −1 ·day −1 from the day of injury until the rats were sacrificed. Rats in the control group were administered an equivalent volume of saline. The rats were fed ad libitum and were maintained under a constant temperature of 20 ± 2°C, with a relative humidity of 50 ± 10%. The epidural scar and the surrounding tissues were collected for subsequent analysis when the rats were sacrificed.
| Macroscopic assessment of EF
Macroscopic examination was performed on the spaces between the dura mater and surrounding soft tissues. Six rats were randomly chosen from each group and were euthanized. Then, the surgical sites were reopened. The extent of adhesion was assessed according to the following scale described by the Rydell (1970) classification: Grade 0 = no adhesions appearing around the dura mater; Grade 1 = thin adhesions observed at the outside of the dura mater, and the adhesions were easily dissected; Grade 2 = moderate adhesions appearing around the dura mater, and it was difficult to dissect the adhesions from the dura mater; Grade 3 = dense fibrous adhesions were tightly adhesive to the dura mater and could not be dissected.
| Determination of hydroxyproline content
Hydroxyproline content (HPC) levels, considered important signs of fibrosis, were analysed 4 weeks post-operatively. Approximately 5 mg of wet scar tissue was obtained from the laminectomy sites.
HPC analysis was performed according to previous studies (Fukui, Tashiro, Hiraoka, Oda, & Nakamura, 2000) . Briefly, the samples were lyophilized, ground, and hydrolysed with 5 ml of 6 mol/L HCl at 110°C for 24 hr. After the hydroxyproline developer (β-dimethylaminobenzaldehyde solution) was added to the samples (0.2 ml) and standards, the absorbances were evaluated at 550 nm by a spectrophotometer. HPC per milligram of scar tissue was recorded.
| Histological analysis
After 4 weeks, six rats of each group were selected and histological analysis was performed. 
| Statistical analysis
Statistical analysis was performed using SPSS 19.0 statistical software.
All data are presented as the means ± standard error of the mean.
Intergroup comparisons were made using one-way analysis of variance, followed by the Tukey's test. Probability values of p < 0.05 were considered statistically significant. showed that expression of cyclin D1 decreased when Sch.B levels increased after being upregulated by TGF-β1. These data suggested that the increased proliferation induced by TGF-β1 in fibroblasts could be suppressed by Sch.B pretreatment.
| Effects of Sch.B on TGF-β1-induced ECM production
The overproduction of ECM is one of the major characteristics of EF.
We found that treatment of fibroblasts with TGF-β1 caused a noticeable increase in the mRNA and protein levels of CTGF, a matricellular protein promoting cell proliferation and migration as well as ECM production. Similarly, the expression of fibronectin and type I collagen, considered the main components of ECM, was also increased by TGF-β1 stimulation. However, Sch.B suppressed all TGF-β1-induced changes in a dose-dependent manner (Figure 3) . The ratios of the intensity of p-ERK relative to total ERK, p-JNK relative to total JNK, and p-p38 relative to total p38. Data are presented as the mean ± SEM, *p < 0.05, **p < 0.01 relative to the control group. # p < 0.05, ## p < 0.01 relative to the TGF-β1-induced group. n = 3 JNK, and p38 by western blotting. As shown in Figure 5 , TGF-β1 greatly increased p-p38, p-ERK, and p-JNK levels, with little effect on p-38, ERK, and JNK levels. After treating the cells with Sch.B, the phosphorylation levels dramatically decreased in a dose-dependent manner, suggesting that Sch.B also influenced the MAPK pathway by inhibiting the phosphorylation of p38, ERK, and JNK ( Figure 5 ).
| Sch.B prevented EF in postlaminectomy rats
To study the therapeutic effect of Sch.B on EF in vivo, a laminectomy rat model was established. Macroscopic examination was done to assess the degree of adhesion of the EF specimens. Severe and dense epidural scar adhesions were observed around the laminectomy sites in the control group, and they were moderate in the Sch.B-treated group. However, there was no formation scar tissue adjacent to the dura mater, for the spinal cord in the sham group was still surrounded by lamina ( Figure S1 ). Thus, the samples in the sham group only did H&E staining. The grades of epidural scar adhesions in rats were classified according to Rydell's classification (Table 2) 
| DISCUSSION
A great number of patients undergoing lumbar laminectomy continue to suffer from EF, a disease characterized by overproduction of ECM, scar adhesion, and chronic nerve radicular pain (Andrychowski et al., 2013; Siqueira et al., 1983) . Although epidural scar tissue adhesions can be removed and the tethered dura mater and adhered nerve root can be released at repeat surgery, the outcomes of secondary surgery for EF are unsatisfactory (Cruccu et al., 2007) . Patients undergoing reoperation face more severe pathological symptoms, including dural lacerations, nerve root injuries, epidural bleeding, and arachnoiditis. Therefore, it is vital to find a method or an agent to prevent the formation of epidural scar fibrosis and adhesions for the treatment of EF. Sch.B, an active ingredient extracted from S. chinensis, was shown to have potent antiproliferative and antifibrotic effects in previous studies (Chun et al., 2014; Min et al., 2008) . In the present study, we demonstrated that Sch.B inhibited the proliferation and ECM production induced by TGF-β1 in primary fibroblasts while also preventing EF in a postlaminectomy rat model.
TGF-β1 is one of the most extensively studied molecules. It has been demonstrated to play a vital role in tissue remodelling during EF after lumbar laminectomy (Zhang et al., 2013) . Following laminectomy, TGF-β1 is produced by a variety of inflammatory cells, including T lymphocytes, macrophages, and platelets, as well as parenchymal cells in the micro-environment of damaged tissue (Ghahary, Shen, Scott, & Tredget, 1994; Prud'homme & Piccirillo, 2000) . Among these cells, fibroblasts are considered to be the predominant cell type involved in the repair process (Zhang, Kong, Ning, et al., 2014; H. Chen, Yan, et al., 2017) . Excessive TGF-β1 initiates cell proliferation and ECM production by fibroblasts, which is widely accepted to be the primary cause of EF (Penn et al., 2012; Yan et al., 2013) . CTGF, a matricellular protein of the CCN family of ECM-associated proteins, regulates a diverse array of cellular functions, including proliferation, migration, and ECM production in various cell types (Fan, Pech, & Karnovsky, 2000; Yamanaka et al., 2008) . TGF-β1 has been demonstrated to be the most potent inducer of CTGF expression (Leask & Abraham, 2004) . Elevated levels of CTGF were found in epidural scar tissue, considered a key factor for EF by stimulating fibroblast proliferation and ECM production, including collagen and fibronectin (Xu et al., 2015) . In the present study, we found that TGF-β1 treatment for 72 hr significantly stimulated production of CTGF as well as type I collagen and fibronectin at the mRNA and protein levels in primary fibroblasts, and both were inhibited by Sch.B in a dose-dependent manner. EdU incorporation assays and western blotting analysis of cyclin D1 confirmed that Sch.B also inhibited the proliferation of fibroblasts. Thus, the results suggested that Sch.B exerted its protective effect by inhibiting cell proliferation and ECM production induced by TGF-β1 in the pathogenesis of EF.
The TGF-β1-induced Smad2/3 pathway regulates several important functions in cells, including differentiation, proliferation, and ECM component synthesis (Derynck & Zhang, 2003; Javelaud & Mauviel, 2004 cytoplasm into the nucleus. In the nucleus, the complexes bind to targeted DNA and interact with transcription factors to regulate gene expression. It has been reported that blocking the Smad2/3 pathway inhibited cell proliferation and ECM synthesis in keloid fibroblasts, in a manner similar to that of scar formation in EF (Phan et al., 2004; Wu et al., 2012) . To determine the mechanism by which Sch.B inhibited the proliferation of fibroblasts and ECM production by suppressing the Smad signalling pathway, we examined the expression of Smad2 and Smad3 using western blotting. We found that Sch.B pretreatment significantly inhibited the TGF-β1-induced Smad signalling pathway by suppressing the phosphorylation of Smad2 and
Smad3. In addition to activation of Smad2/3 signalling, TGF-β1 also activates several Smad-independent pathways, including the MAPK signalling pathways that were also of great importance in modulating the outcome of TGF-β1-induced Smad signalling (Derynck & Zhang, 2003; Javelaud & Mauviel, 2004) . Recently, the important role for the MAPK-Smad crosstalk pathway in fibrosis has been demonstrated in numerous studies (Javelaud & Mauviel, 2004) . The phosphorylation levels and nuclear translocation of Smad2 and Smad3 were increased via the MAPK signalling pathways in TGF-β1-treated cells (Engel, McDonnell, Law, & Moses, 1999; Park, Yoon, Lee, & Park, 2015) .
Interestingly, we also showed that Sch.B pretreatment downregulated TGF-β1-induced phosphorylation of ERK, JNK, and p38 significantly.
Taken together, these results suggested that the Smad2/3 and MAPK pathways were involved in the protective effect of Sch.B in EF.
To further investigate the effects of Sch.B in vivo, we established a postlaminectomy EF model. Rydell scores were better in the group treated with Sch.B than those in the control group. The number of fibroblasts, density of collagen, HPC, and the production of fibronectin and type I collagen of the epidural scar tissues in the Sch.B-treated group were significantly lower than those of the control group. These results and those of the in vitro experiments further suggested that Sch.B provided potential value in preventing epidural scar adhesion.
| CONCLUSIONS
Based on the in vivo and in vitro results of our study, we suggest that Sch.B may be a promising intervention for treating EF. The protective effect of Sch.B on EF was accomplished by inhibiting fibroblast proliferation and ECM production, whereas inhibition of the activation of the Smad2/3 and MAPK pathways may be the underling mechanism of it.
